Page last updated: 2024-08-21

fluorobenzenes and Acute Confusional Senile Dementia

fluorobenzenes has been researched along with Acute Confusional Senile Dementia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crisby, M; Famer, D; Wahlund, LO1
Albani, D; Confaloni, A; Crestini, A; Forloni, G; Iazeolla, M; Piscopo, P; Rivabene, R1
Barone, E; Butterfield, DA; Mancuso, C1
Beher, D; Owens, AP; Shearman, MS; Wrigley, JD1
Orr, JD1

Reviews

1 review(s) available for fluorobenzenes and Acute Confusional Senile Dementia

ArticleYear
Statins in the spectrum of neurologic disease.
    Current atherosclerosis reports, 2008, Volume: 10, Issue:1

    Topics: Alzheimer Disease; Animals; Atherosclerosis; Cardiovascular Diseases; Diabetic Neuropathies; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Multiple Sclerosis; Nervous System Diseases; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Pyrimidines; Reactive Oxygen Species; Rosuvastatin Calcium; Stroke; Sulfonamides

2008

Other Studies

4 other study(ies) available for fluorobenzenes and Acute Confusional Senile Dementia

ArticleYear
Rosuvastatin reduces microglia in the brain of wild type and ApoE knockout mice on a high cholesterol diet; implications for prevention of stroke and AD.
    Biochemical and biophysical research communications, 2010, Nov-12, Volume: 402, Issue:2

    Topics: Alzheimer Disease; Animals; Apolipoproteins E; Brain; Cholesterol; Diet; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Mice; Mice, Knockout; Microglia; Pyrimidines; Rosuvastatin Calcium; Stroke; Sulfonamides

2010
Rosuvastatin and thapsigargin modulate γ-secretase gene expression and APP processing in a human neuroglioma model.
    Journal of molecular neuroscience : MN, 2011, Volume: 43, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Cell Line, Tumor; Enzyme Inhibitors; Fluorobenzenes; Gene Expression; Glioma; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Thapsigargin

2011
Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders.
    Pharmacological research, 2011, Volume: 64, Issue:3

    Topics: Alzheimer Disease; Animals; Atorvastatin; Cholesterol; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Neurodegenerative Diseases; Pyrimidines; Pyrroles; Quinolines; Rosuvastatin Calcium; Sulfonamides

2011
Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity.
    Journal of neurochemistry, 2002, Volume: 82, Issue:3

    Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Antibodies, Monoclonal; Antibody Specificity; Aspartic Acid Endopeptidases; Cell Line; Culture Media, Conditioned; Endopeptidases; Enzyme Activation; Enzyme Inhibitors; Fluorobenzenes; Humans; Kidney; Mass Spectrometry; Metalloendopeptidases; Molecular Sequence Data; Neuroblastoma; Pentanoic Acids; Peptide Fragments; Peptides; Phenylalanine; Recombinant Proteins; Thiophenes; Transfection

2002